Motor pathway excitability in ATP13A2 mutation carriers: A transcranial magnetic stimulation study

A compound heterozygous mutation in the ATP13A2 gene is associated with increased intracortical inhibition. In addition, some aspects of interhemispheric inhibition are increased in the presence of a single ATP13A2 mutation.